Featured Research

from universities, journals, and other organizations

Complications, Death Rates Similar At Bariatric Surgery Centers Of Excellence, Other Hospitals

Date:
April 20, 2009
Source:
JAMA and Archives Journals
Summary:
Patients who undergo bariatric surgery at hospitals designated as centers of excellence do not appear to have lower mortality rates or lower rates of complications than those whose procedures are performed at other hospitals, according to a new article.

Patients who undergo bariatric surgery at hospitals designated as centers of excellence do not appear to have lower mortality rates or lower rates of complications than those whose procedures are performed at other hospitals, according to a new article.

Center of excellence designation is awarded to bariatric surgery centers by the American College of Surgeons or the American Society for Metabolic and Bariatric Surgery, according to background information in the article. The nearly identical guidelines require that centers perform at least 125 operations per year; employ a bariatric surgery coordinator and personnel to follow up patients long-term; and enter outcomes into proprietary databases, which requires trained staff and a subscription to a database. "These criteria make intuitive sense but lack an evidence base for their application," the author writes. In 2006, the Centers for Medicaid and Medicare Services began requiring that patients they insure undergo bariatric surgery at designated centers of excellence.

Edward H. Livingston, M.D., of the University of Texas Southwestern School of Medicine and Department of Veterans Affairs, Dallas, analyzed data from the 2005 National Inpatient Survey for 19,363 patients who underwent bariatric surgery that year, including 5,420 (28 percent) whose procedures were performed at bariatric surgery centers of excellence. Overall, 0.1 percent of patients died in the hospital and 6.4 percent developed complications.

More bariatric operations were performed at the 9.5 percent (24 of 253) of hospitals in the database designated as centers of excellence (an average of 226 procedures per year vs. 79 at other facilities). At centers of excellence, 0.17 percent of patients died and 6.3 percent developed complications, compared with a 0.09 death rate and 6.4 percent complication rate at other facilities. Patients spent an average of 2.6 days in the hospital both at centers of excellence and other facilities, but average costs per patient were higher at centers of excellence ($11,527 vs. $10,984).

"It has been shown that the minimal annual procedure volume required to be designated as a center of excellence (125 cases per year) does not necessarily result in better outcomes and that the minimum volume requirement is not evidence based. Most important, this volume criterion significantly restricts access for bariatric surgery care," Dr. Livingston writes. "The number of bariatric operations performed each year was the most striking difference between bariatric surgery centers of excellence and hospitals that were not centers of excellence. Patient and facility characteristics were similar as were complication and death rates."

"Designation as a bariatric surgery center of excellence does not ensure better outcomes. Neither does high annual procedure volume," Dr. Livingston concludes. "Extra expenses associated with center of excellence designation may not be warranted."

This study was funded by the Hudson-Penn endowment, grants from the National Institutes of Health and a grant from the Department of Veterans Affairs.


Story Source:

The above story is based on materials provided by JAMA and Archives Journals. Note: Materials may be edited for content and length.


Journal Reference:

  1. Edward H. Livingston, MD. Bariatric Surgery Outcomes at Designated Centers of Excellence vs Nondesignated Programs. Arch Surg., 2009;144(4):319-325

Cite This Page:

JAMA and Archives Journals. "Complications, Death Rates Similar At Bariatric Surgery Centers Of Excellence, Other Hospitals." ScienceDaily. ScienceDaily, 20 April 2009. <www.sciencedaily.com/releases/2009/04/090420170804.htm>.
JAMA and Archives Journals. (2009, April 20). Complications, Death Rates Similar At Bariatric Surgery Centers Of Excellence, Other Hospitals. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2009/04/090420170804.htm
JAMA and Archives Journals. "Complications, Death Rates Similar At Bariatric Surgery Centers Of Excellence, Other Hospitals." ScienceDaily. www.sciencedaily.com/releases/2009/04/090420170804.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins